58 press releases
BRAIN-AF Study Receives Canadian Institutes of Health Research Grant
March 15, 2021
The Montreal Heart Institute announces that the BRAIN-AF study has received a $1.4 million grant from the Canadian Institutes of Health Research. Seeking to better understand the effects of cardiovascular disease on the cognitive decline of the brain, the study will be able to recruit participants remotely thanks to this funding.
$281,205 raised for the prevention of cardiovascular diseases
March 11, 2021
The Montreal Heart Institute Foundation, in collaboration with IGA, announces that the $2 Does the Heart Good fundraiser concluded with a total of $281,205 raised. This campaign was held as part of Heart Month, from February 4 to 24, in nearly 300 IGA supermarkets in Quebec and New Brunswick.
Webinar: Plan your enduring legacy
March 4, 2021
Do you want to leave behind a legacy that supports a cause that is dear to your heart? A legacy that takes your family and financial situation into consideration? Our estate planning experts will guide you through the steps of making a bequest during a virtual information session.
A donation from the heart by Canadian Pacific
February 25, 2021
The Montreal Heart Institute Foundation is proud to announce a donation of $50,000 from Canadian Pacific as part of its "CP Has Heart" campaign to acquire a DNA sequencer. This state-of-the-art device will, among other things, optimize the treatment of patients with COVID-19.
Loto Cardio is back!
February 15, 2021
Loto Cardio raises funds to support Montreal Heart Institute's innovative and priority projects.
IGA joins forces with the Foundation
February 4, 2021
From February 4 to 24, head to one of 300 participating IGA grocery stores in Quebec and New Brunswick to take part in the annual $2 does the heart good campaign that raises funds for the Foundation.
Colchicine reduces the risk of COVID-19-related complications
January 22, 2021
The Montreal Heart Institute announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19.
Supporting people with type 2 diabetes throughout the pandemic
January 14, 2021
When the pandemic forced gyms to close, it caused some disruption to the plans that had been developed for patients by the team at the Montreal Heart Institute’s Diabetes Prevention Clinic sponsored by Sun Life. As people with type 2 diabetes are more vulnerable when it comes to COVID-19, it was important they remained safe at home. Fortunately, when public health restrictions were implemented, telehealth was there to make remote monitoring possible.
Montreal Auto Show Charity Preview : A new formula for the 17th edition!
January 4, 2021
Starting January 23rd, join us for the 17th virtual edition of the Montreal Auto Show Charity Preview.
New data supports development of colchicine for the prevention of acute respiratory distress syndrome
December 3, 2020
The Montreal Heart Institute has announced that colchicine, a widely available low-cost drug, reduces acute lung injury, acute respiratory distress syndrome and respiratory failure in pre-clinical models. The article reporting these results was published yesterday by the Public Library of Science ONE (PLOS ONE).